Health‐related Quality of Life in Patients with Relapsed/refractory Multiple Myeloma Treated with Pomalidomide and Dexamethasone ± Subcutaneous Daratumumab: Patient‐reported Outcomes from the APOLLO Trial
American Journal of Hematology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined